Gilead seeks FDA approval for once-daily Descovy to treat HIV pre-exposure prophylaxis

Image: Gilead Sciences is seeking approval from FDA for once-daily Descovy for treatment of HIV pre-exposure prophylaxis. Photo: courtesy of cooldesign / FreeDigitalPhotos.net.